By Dr Anna McNulty

Conference Posters

Vaccher S; Grulich A; Haire B; Templeton D; McNulty A; Foster R; Ooi C; Poynten M; Prestage G; Zablotska-Manos I, 2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Siefried KJ; McAllister J; McNulty A; Read TR; Pearce A; Richardson R; Carr A, 2014, 'Safety and tolerability of, and adherence to, co-formulated emtricitabine-rilpivirine-tenofovir used as HIV non-occupational post-exposure prophylaxis in men who have sex with men', Sydney, Australia, presented at The St Vincent’s and Mater Health Research Symposium, Sydney, Australia, 11 September 2014 - 11 September 2014

Back to profile page